NOTABLE LABS, LTD. Research And Development Expense
NOTABLE LABS, LTD. reported Research And Development Expense of $4.80 million for the 3-month period ending 2020-09-30, per its 6-K filed 2020-11-16.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2020-11-16
- NOTABLE LABS, LTD. research and development expense for the quarter ending 2020-09-30 was $4.80M, a 26.61% increase year-over-year.
- NOTABLE LABS, LTD. research and development expense for the quarter ending 2020-06-30 was $4.87M, a 30.46% increase year-over-year.
- NOTABLE LABS, LTD. research and development expense for the quarter ending 2020-03-31 was $4.75M, a 43.62% increase year-over-year.
- NOTABLE LABS, LTD. research and development expense for the quarter ending 2019-12-31 was $4.64M, a 47.33% increase year-over-year.
| Period end | Research And Development Expense 3 month | Research And Development Expense 3 month as first filed | Research And Development Expense 6 month | Research And Development Expense 6 month as first filed | Research And Development Expense 9 month | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2020-09-30 | $4.80M 6-K · filed 2020-11-16 | $9.67M derived: sum of 2 quarters · filed 2020-11-16 | $14.42M 6-K · filed 2020-11-16 | $19.06M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2020-06-30 | $4.87M 6-K · filed 2020-08-13 | $9.62M 6-K · filed 2020-08-13 | $14.25M derived: sum of 3 quarters · filed 2020-08-13 | $18.05M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2020-03-31 | $4.75M 6-K · filed 2020-05-14 | $9.39M derived: sum of 2 quarters · filed 2020-05-14 | $13.18M derived: sum of 3 quarters · filed 2020-11-16 | $16.91M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-12-31 | $4.64M derived: 20-F 12 month − 6-K 9 month · filed 2020-03-19 | $8.43M derived: sum of 2 quarters · filed 2020-11-16 | $12.16M derived: sum of 3 quarters · filed 2020-11-16 | $15.47M 20-F · filed 2020-03-19 | |||
| 2019-09-30 | $3.79M 6-K · filed 2020-11-16 | $7.52M derived: sum of 2 quarters · filed 2020-11-16 | $10.83M 6-K · filed 2020-11-16 | $13.98M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | $3.73M 6-K · filed 2020-08-13 | -$3.73M 6-K · filed 2019-08-29 | $7.04M 6-K · filed 2020-08-13 | -$7.04M 6-K · filed 2019-08-29 | $10.19M derived: sum of 3 quarters · filed 2020-08-13 | $14.32M derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $3.31M 6-K · filed 2020-05-14 | $6.46M derived: sum of 2 quarters · filed 2020-05-14 | $10.59M derived: sum of 3 quarters · filed 2020-05-14 | $7.70M derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | $3.15M derived: 20-F 12 month − 6-K 9 month · filed 2020-03-19 | $7.29M derived: sum of 2 quarters · filed 2020-03-19 | $4.39M derived: sum of 3 quarters · filed 2020-03-19 | $15.94M 20-F · filed 2020-03-19 | -$15.94M 20-F · filed 2019-03-28 | ||
| 2018-09-30 | $4.14M 6-K · filed 2019-11-14 | $1.24M derived: sum of 2 quarters · filed 2019-11-14 | $12.79M 6-K · filed 2019-11-14 | ||||
| 2018-06-30 | -$2.90M 6-K · filed 2019-08-29 | -$8.65M 6-K · filed 2019-08-29 | |||||
| 2017-12-31 | $17.77M 20-F · filed 2020-03-19 | -$17.77M 20-F · filed 2018-03-15 | |||||
| 2016-12-31 | -$12.45M 20-F · filed 2019-03-28 | ||||||
| 2015-12-31 | -$11.20M 20-F · filed 2018-03-15 |